Interleukin-22 promotes T helper 1 (Th1)/Th17 immunity in chlamydial lung infection

Molecular Medicine

Volumn 20, Issue 1, 2014, Pages 109-119

  Peng, Ying ^a,b   Gao, Xiaoling ^a   Yang, Jie ^a   Shekhar, Sudhanshu ^a   Wang, Shuhe ^a   Fan, Yijun ^a   Zhao, Weiming ^b   Yang, Xi ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; CYTOKINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE SEVERITY; DOWN REGULATION; HOST RESISTANCE; LUNG INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; CHLAMYDIA MURIDARUM; GENETICS; IMMUNOLOGY; LUNG; LUNG DISEASE; LYMPH NODE; PATHOLOGY; SPLEEN;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOKINES; LUNG; LUNG DISEASES; LYMPH NODES; MALE; MICE, INBRED C57BL; RNA, MESSENGER; SPLEEN; TH1 CELLS; TH17 CELLS;

EID: 84897861757     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00115     Document Type: Article

References (40)

1. Dumoutier L, Louahed J, Renauld JC. (2000) Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164:1814-9.
2. Witte E, Witte K, Warszawska K, Sabat R, Wolk K. (2010) Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 21:365-79.
3. Zenewicz LA, Flavell RA. (2011) Recent advances in IL-22 biology. Int. Immunol. 23:159-63.
4. Wolk K, et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36:1309-23.
5. Wolk K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity. 21:241-54.
6. Zheng Y, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-9.
7. Aujla SJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-81.
8. Sugimoto K, et al. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118:534-44.
9. Brand S, et al. (2006) IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G827-38.
10. Pitta MG, et al. (2009) IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J. Clin. Invest. 119:2379-87.
11. Guo H, Topham DJ. (2010) Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection. J. Virol. 84:7750-9.
12. Ivanov, II, et al. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 139:485-98.
13. Lin Y, et al. (2009) Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity. 31:799-810.
14. Graham AC, et al. (2011) IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection. PLoS One. 6:e17171.
15. Yao S, et al. (2010) Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis. PLoS Pathog. 6:e1000789.
16. Wilson MS, et al. (2010) Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 184:4378-90.
17. Schachter J. (1978) Chlamydial infections (first of three parts). N. Engl. J. Med. 298:428-35.
18. Morrison RP, Caldwell HD. (2002) Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-51.
19. Geng Y, et al. (2000) Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect. Immun. 68:2245-53.
20. Yang X, HayGlass KT, Brunham RC. (1996) Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J. Immunol. 156:4338-44.
21. Wang S, Fan Y, Brunham RC, Yang X. (1999) IFNgamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur. J. Immunol. 29:3782-92.
22. Bai H, et al. (2009) IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 183:5886-95.
23. Zhang X, et al. (2009) A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J. Immunol. 183:1291-300.
24. Zhang Y, et al. (2012) IL-17A synergizes with IFNgamma to upregulate iNOS and NO production and inhibit chlamydial growth. PloS One. 7:e39214.
25. Gao X, et al. (2012) Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling. PloS one. 7:e52657.
26. Jha R, et al. (2011) Spontaneous secretion of interleukin-17 and-22 by human cervical cells in Chlamydia trachomatis infection. Microbes Infect. 13:167-78.
27. Joyee AG, Qiu H, Fan Y, Wang S, Yang X. (2008) Natural killer T cells are critical for dendritic cells to induce immunity in Chlamydial pneumonia. Am. J. Respir. Crit. Care Med. 178:745-56.
28. Bilenki L, et al. (2006) Adoptive transfer of CD8alpha+ dendritic cells (DC) isolated from mice infected with Chlamydia muridarum are more potent in inducing protective immunity than CD8alpha-DC. J. Immunol. 177:7067-75.
29. Han X, et al. (2006) Chlamydia infection induces ICOS ligand-expressing and IL-10-producing dendritic cells that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice. J. Immunol. 176:5232-9.
30. Qiu H, et al. (2008) Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J. Immunol. 181:2092-102.
31. Zhao L, et al. (2011) Differential modulating effect of natural killer (NK) T cells on interferongamma production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection. Immunology. 134:172-84.
32. Kolls JK, Khader SA. (2010) The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 21:443-8.
33. Brunham RC, Rey-Ladino J. (2005) Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5:149-61.
34. Kimura A, Kishimoto T. (2010) IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 40:1830-5.
35. Zhou L, et al. (2008) TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 453:236-40.
36. Shevach EM. (2000) Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423-49.
37. Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC. (2000) IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 1:488-94.
38. Kotenko SV, et al. (2001) Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol. Chem. 276:2725-32.
39. Lejeune D, et al. (2002) Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol. Chem. 277:33676-82.
40. Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R. (2004) Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4:679-91.